Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8714688 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 10 Pages |
Abstract
POIT may be cost-effective in a long-term economic model. However, treated patients may experience a greater rate of peanut-associated allergic reactions and anaphylaxis. The analysis was sensitive to rates of accidental allergic reactions, therapy-associated adverse events, and likelihood of therapy-induced tolerance.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marcus S. MD, MS,